img

Global Avian Influenza Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Avian Influenza Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.
Avian Influenza Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Avian Influenza Vaccines market is projected to reach US$ 1386.6 million in 2034, increasing from US$ 949 million in 2022, with the CAGR of 5.5% during the period of 2024 to 2034. Demand from Chicken Avian Influenza Vaccines and Duck & Goose Avian Influenza Vaccines are the major drivers for the industry.
Global Avian Influenza Vaccines key players include Merial, QYH Biotech, DHN, HVRI, etc. Global top four manufacturers hold a share over 80%.
China is the largest market, with a share about 45%, followed by Asia (Ex.China), and North America, both have a share about 40 percent.
In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Avian Influenza Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merial
QYH Biotech
DHN
HVRI
CEVA
Elanco (Lohmann )
Yebio
Zoetis
FATRO
Kyoto Biken
CAVAC
Ringpu Biology
Vaksindo
ChengDu Tecbond
Sindh Poultry Vaccine Centre
Merck Animal Health
Medion
Avimex Animal Health
JOVAC
Bio-Labs
Segment by Type
H5+H7 Avian Influenza Vaccines
H9 Avian Influenza Vaccines

Segment by Application


Chicken Avian Influenza Vaccines
Duck & Goose Avian Influenza Vaccines
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Avian Influenza Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Avian Influenza Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Avian Influenza Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Avian Influenza Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Avian Influenza Vaccines introduction, etc. Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Avian Influenza Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Avian Influenza Vaccines Market Overview
1.1 Avian Influenza Vaccines Product Overview
1.2 Avian Influenza Vaccines Market Segment by Type
1.2.1 H5+H7 Avian Influenza Vaccines
1.2.2 H9 Avian Influenza Vaccines
1.3 Global Avian Influenza Vaccines Market Size by Type
1.3.1 Global Avian Influenza Vaccines Market Size Overview by Type (2018-2034)
1.3.2 Global Avian Influenza Vaccines Historic Market Size Review by Type (2018-2024)
1.3.3 Global Avian Influenza Vaccines Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Avian Influenza Vaccines Sales Breakdown by Type (2018-2024)
1.4.2 Europe Avian Influenza Vaccines Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Avian Influenza Vaccines Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Avian Influenza Vaccines Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Avian Influenza Vaccines Sales Breakdown by Type (2018-2024)
2 Global Avian Influenza Vaccines Market Competition by Company
2.1 Global Top Players by Avian Influenza Vaccines Sales (2018-2024)
2.2 Global Top Players by Avian Influenza Vaccines Revenue (2018-2024)
2.3 Global Top Players by Avian Influenza Vaccines Price (2018-2024)
2.4 Global Top Manufacturers Avian Influenza Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Avian Influenza Vaccines Market Competitive Situation and Trends
2.5.1 Avian Influenza Vaccines Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Avian Influenza Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Avian Influenza Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Avian Influenza Vaccines Market
2.8 Key Manufacturers Avian Influenza Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Avian Influenza Vaccines Status and Outlook by Region
3.1 Global Avian Influenza Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Avian Influenza Vaccines Historic Market Size by Region
3.2.1 Global Avian Influenza Vaccines Sales in Volume by Region (2018-2024)
3.2.2 Global Avian Influenza Vaccines Sales in Value by Region (2018-2024)
3.2.3 Global Avian Influenza Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Avian Influenza Vaccines Forecasted Market Size by Region
3.3.1 Global Avian Influenza Vaccines Sales in Volume by Region (2024-2034)
3.3.2 Global Avian Influenza Vaccines Sales in Value by Region (2024-2034)
3.3.3 Global Avian Influenza Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Avian Influenza Vaccines by Application
4.1 Avian Influenza Vaccines Market Segment by Application
4.1.1 Chicken Avian Influenza Vaccines
4.1.2 Duck & Goose Avian Influenza Vaccines
4.1.3 Other
4.2 Global Avian Influenza Vaccines Market Size by Application
4.2.1 Global Avian Influenza Vaccines Market Size Overview by Application (2018-2034)
4.2.2 Global Avian Influenza Vaccines Historic Market Size Review by Application (2018-2024)
4.2.3 Global Avian Influenza Vaccines Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Avian Influenza Vaccines Sales Breakdown by Application (2018-2024)
4.3.2 Europe Avian Influenza Vaccines Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Avian Influenza Vaccines Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Avian Influenza Vaccines Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Avian Influenza Vaccines Sales Breakdown by Application (2018-2024)
5 North America Avian Influenza Vaccines by Country
5.1 North America Avian Influenza Vaccines Historic Market Size by Country
5.1.1 North America Avian Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Avian Influenza Vaccines Sales in Volume by Country (2018-2024)
5.1.3 North America Avian Influenza Vaccines Sales in Value by Country (2018-2024)
5.2 North America Avian Influenza Vaccines Forecasted Market Size by Country
5.2.1 North America Avian Influenza Vaccines Sales in Volume by Country (2024-2034)
5.2.2 North America Avian Influenza Vaccines Sales in Value by Country (2024-2034)
6 Europe Avian Influenza Vaccines by Country
6.1 Europe Avian Influenza Vaccines Historic Market Size by Country
6.1.1 Europe Avian Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Avian Influenza Vaccines Sales in Volume by Country (2018-2024)
6.1.3 Europe Avian Influenza Vaccines Sales in Value by Country (2018-2024)
6.2 Europe Avian Influenza Vaccines Forecasted Market Size by Country
6.2.1 Europe Avian Influenza Vaccines Sales in Volume by Country (2024-2034)
6.2.2 Europe Avian Influenza Vaccines Sales in Value by Country (2024-2034)
7 Asia-Pacific Avian Influenza Vaccines by Region
7.1 Asia-Pacific Avian Influenza Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Avian Influenza Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Avian Influenza Vaccines Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Avian Influenza Vaccines Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Avian Influenza Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Avian Influenza Vaccines Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Avian Influenza Vaccines Sales in Value by Region (2024-2034)
8 Latin America Avian Influenza Vaccines by Country
8.1 Latin America Avian Influenza Vaccines Historic Market Size by Country
8.1.1 Latin America Avian Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Avian Influenza Vaccines Sales in Volume by Country (2018-2024)
8.1.3 Latin America Avian Influenza Vaccines Sales in Value by Country (2018-2024)
8.2 Latin America Avian Influenza Vaccines Forecasted Market Size by Country
8.2.1 Latin America Avian Influenza Vaccines Sales in Volume by Country (2024-2034)
8.2.2 Latin America Avian Influenza Vaccines Sales in Value by Country (2024-2034)
9 Middle East and Africa Avian Influenza Vaccines by Country
9.1 Middle East and Africa Avian Influenza Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Avian Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Avian Influenza Vaccines Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Avian Influenza Vaccines Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Avian Influenza Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Avian Influenza Vaccines Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Avian Influenza Vaccines Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merial
10.1.1 Merial Company Information
10.1.2 Merial Introduction and Business Overview
10.1.3 Merial Avian Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Merial Avian Influenza Vaccines Products Offered
10.1.5 Merial Recent Development
10.2 QYH Biotech
10.2.1 QYH Biotech Company Information
10.2.2 QYH Biotech Introduction and Business Overview
10.2.3 QYH Biotech Avian Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.2.4 QYH Biotech Avian Influenza Vaccines Products Offered
10.2.5 QYH Biotech Recent Development
10.3 DHN
10.3.1 DHN Company Information
10.3.2 DHN Introduction and Business Overview
10.3.3 DHN Avian Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.3.4 DHN Avian Influenza Vaccines Products Offered
10.3.5 DHN Recent Development
10.4 HVRI
10.4.1 HVRI Company Information
10.4.2 HVRI Introduction and Business Overview
10.4.3 HVRI Avian Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.4.4 HVRI Avian Influenza Vaccines Products Offered
10.4.5 HVRI Recent Development
10.5 CEVA
10.5.1 CEVA Company Information
10.5.2 CEVA Introduction and Business Overview
10.5.3 CEVA Avian Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.5.4 CEVA Avian Influenza Vaccines Products Offered
10.5.5 CEVA Recent Development
10.6 Elanco (Lohmann )
10.6.1 Elanco (Lohmann ) Company Information
10.6.2 Elanco (Lohmann ) Introduction and Business Overview
10.6.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Elanco (Lohmann ) Avian Influenza Vaccines Products Offered
10.6.5 Elanco (Lohmann ) Recent Development
10.7 Yebio
10.7.1 Yebio Company Information
10.7.2 Yebio Introduction and Business Overview
10.7.3 Yebio Avian Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Yebio Avian Influenza Vaccines Products Offered
10.7.5 Yebio Recent Development
10.8 Zoetis
10.8.1 Zoetis Company Information
10.8.2 Zoetis Introduction and Business Overview
10.8.3 Zoetis Avian Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Zoetis Avian Influenza Vaccines Products Offered
10.8.5 Zoetis Recent Development
10.9 FATRO
10.9.1 FATRO Company Information
10.9.2 FATRO Introduction and Business Overview
10.9.3 FATRO Avian Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.9.4 FATRO Avian Influenza Vaccines Products Offered
10.9.5 FATRO Recent Development
10.10 Kyoto Biken
10.10.1 Kyoto Biken Company Information
10.10.2 Kyoto Biken Introduction and Business Overview
10.10.3 Kyoto Biken Avian Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Kyoto Biken Avian Influenza Vaccines Products Offered
10.10.5 Kyoto Biken Recent Development
10.11 CAVAC
10.11.1 CAVAC Company Information
10.11.2 CAVAC Introduction and Business Overview
10.11.3 CAVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.11.4 CAVAC Avian Influenza Vaccines Products Offered
10.11.5 CAVAC Recent Development
10.12 Ringpu Biology
10.12.1 Ringpu Biology Company Information
10.12.2 Ringpu Biology Introduction and Business Overview
10.12.3 Ringpu Biology Avian Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Ringpu Biology Avian Influenza Vaccines Products Offered
10.12.5 Ringpu Biology Recent Development
10.13 Vaksindo
10.13.1 Vaksindo Company Information
10.13.2 Vaksindo Introduction and Business Overview
10.13.3 Vaksindo Avian Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Vaksindo Avian Influenza Vaccines Products Offered
10.13.5 Vaksindo Recent Development
10.14 ChengDu Tecbond
10.14.1 ChengDu Tecbond Company Information
10.14.2 ChengDu Tecbond Introduction and Business Overview
10.14.3 ChengDu Tecbond Avian Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.14.4 ChengDu Tecbond Avian Influenza Vaccines Products Offered
10.14.5 ChengDu Tecbond Recent Development
10.15 Sindh Poultry Vaccine Centre
10.15.1 Sindh Poultry Vaccine Centre Company Information
10.15.2 Sindh Poultry Vaccine Centre Introduction and Business Overview
10.15.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Products Offered
10.15.5 Sindh Poultry Vaccine Centre Recent Development
10.16 Merck Animal Health
10.16.1 Merck Animal Health Company Information
10.16.2 Merck Animal Health Introduction and Business Overview
10.16.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Merck Animal Health Avian Influenza Vaccines Products Offered
10.16.5 Merck Animal Health Recent Development
10.17 Medion
10.17.1 Medion Company Information
10.17.2 Medion Introduction and Business Overview
10.17.3 Medion Avian Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Medion Avian Influenza Vaccines Products Offered
10.17.5 Medion Recent Development
10.18 Avimex Animal Health
10.18.1 Avimex Animal Health Company Information
10.18.2 Avimex Animal Health Introduction and Business Overview
10.18.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Avimex Animal Health Avian Influenza Vaccines Products Offered
10.18.5 Avimex Animal Health Recent Development
10.19 JOVAC
10.19.1 JOVAC Company Information
10.19.2 JOVAC Introduction and Business Overview
10.19.3 JOVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.19.4 JOVAC Avian Influenza Vaccines Products Offered
10.19.5 JOVAC Recent Development
10.20 Bio-Labs
10.20.1 Bio-Labs Company Information
10.20.2 Bio-Labs Introduction and Business Overview
10.20.3 Bio-Labs Avian Influenza Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Bio-Labs Avian Influenza Vaccines Products Offered
10.20.5 Bio-Labs Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Avian Influenza Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Avian Influenza Vaccines Industrial Chain Analysis
11.4 Avian Influenza Vaccines Market Dynamics
11.4.1 Avian Influenza Vaccines Industry Trends
11.4.2 Avian Influenza Vaccines Market Drivers
11.4.3 Avian Influenza Vaccines Market Challenges
11.4.4 Avian Influenza Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Avian Influenza Vaccines Distributors
12.3 Avian Influenza Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of H5+H7 Avian Influenza Vaccines
Table 2. Major Company of H9 Avian Influenza Vaccines
Table 3. Global Avian Influenza Vaccines Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Avian Influenza Vaccines Sales by Type (2018-2024) & (M Doses)
Table 5. Global Avian Influenza Vaccines Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Avian Influenza Vaccines Sales by Type (2018-2024) & (US& Million)
Table 7. Global Avian Influenza Vaccines Market Share in Value by Type (2018-2024)
Table 8. Global Avian Influenza Vaccines Price by Type (2018-2024) & (USD/K Doses)
Table 9. Global Avian Influenza Vaccines Sales by Type (2024-2034) & (M Doses)
Table 10. Global Avian Influenza Vaccines Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Avian Influenza Vaccines Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Avian Influenza Vaccines Sales Market Share in Value by Type (2024-2034)
Table 13. Global Avian Influenza Vaccines Price by Type (2024-2034) & (USD/K Doses)
Table 14. North America Avian Influenza Vaccines Sales by Type (2018-2024) & (M Doses)
Table 15. North America Avian Influenza Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Avian Influenza Vaccines Sales (M Doses) by Type (2018-2024)
Table 17. Europe Avian Influenza Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Avian Influenza Vaccines Sales (M Doses) by Type (2018-2024)
Table 19. Asia-Pacific Avian Influenza Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Avian Influenza Vaccines Sales (M Doses) by Type (2018-2024)
Table 21. Latin America Avian Influenza Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Avian Influenza Vaccines Sales (M Doses) by Type (2018-2024)
Table 23. Middle East and Africa Avian Influenza Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Avian Influenza Vaccines Sales by Company (2018-2024) & (M Doses)
Table 25. Global Avian Influenza Vaccines Sales Share by Company (2018-2024)
Table 26. Global Avian Influenza Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Avian Influenza Vaccines Revenue Share by Company (2018-2024)
Table 28. Global Market Avian Influenza Vaccines Price by Company (2018-2024) & (USD/K Doses)
Table 29. Global Avian Influenza Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Avian Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Avian Influenza Vaccines as of 2022)
Table 32. Date of Key Manufacturers Enter into Avian Influenza Vaccines Market
Table 33. Key Manufacturers Avian Influenza Vaccines Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Avian Influenza Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Avian Influenza Vaccines Sales by Region (2018-2024) & (M Doses)
Table 37. Global Avian Influenza Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Avian Influenza Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Avian Influenza Vaccines Sales Market Share in Value by Region (2018-2024)
Table 40. Global Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 41. Global Avian Influenza Vaccines Sales by Region (2024-2034) & (M Doses)
Table 42. Global Avian Influenza Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Avian Influenza Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Avian Influenza Vaccines Sales Market Share in Value by Region (2024-2034)
Table 45. Global Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2024-2034)
Table 46. Global Avian Influenza Vaccines Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Avian Influenza Vaccines Sales by Application (2018-2024) & (M Doses)
Table 48. Global Avian Influenza Vaccines Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Avian Influenza Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Avian Influenza Vaccines Sales Market Share in Value by Application (2018-2024)
Table 51. Global Avian Influenza Vaccines Price by Application (2018-2024) & (USD/K Doses)
Table 52. Global Avian Influenza Vaccines Sales by Application (2024-2034) & (M Doses)
Table 53. Global Avian Influenza Vaccines Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Avian Influenza Vaccines Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Avian Influenza Vaccines Sales Market Share in Value by Application (2024-2034)
Table 56. Global Avian Influenza Vaccines Price by Application (2024-2034) & (USD/K Doses)
Table 57. North America Avian Influenza Vaccines Sales by Application (2018-2024) (M Doses)
Table 58. North America Avian Influenza Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Avian Influenza Vaccines Sales by Application (2018-2024) (M Doses)
Table 60. Europe Avian Influenza Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Avian Influenza Vaccines Sales by Application (2018-2024) (M Doses)
Table 62. Asia-Pacific Avian Influenza Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Avian Influenza Vaccines Sales by Application (2018-2024) (M Doses)
Table 64. Latin America Avian Influenza Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Avian Influenza Vaccines Sales by Application (2018-2024) (M Doses)
Table 66. Middle East and Africa Avian Influenza Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Avian Influenza Vaccines Sales by Country (2018-2024) & (M Doses)
Table 68. North America Avian Influenza Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Avian Influenza Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Avian Influenza Vaccines Sales Market Share in Value by Country (2018-2024)
Table 71. North America Avian Influenza Vaccines Sales by Country (2024-2034) & (M Doses)
Table 72. North America Avian Influenza Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Avian Influenza Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Avian Influenza Vaccines Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Avian Influenza Vaccines Sales by Country (2018-2024) & (M Doses)
Table 76. Europe Avian Influenza Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Avian Influenza Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Avian Influenza Vaccines Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Avian Influenza Vaccines Sales by Country (2024-2034) & (M Doses)
Table 80. Europe Avian Influenza Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Avian Influenza Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Avian Influenza Vaccines Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Avian Influenza Vaccines Sales by Region (2018-2024) & (M Doses)
Table 84. Asia-Pacific Avian Influenza Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Avian Influenza Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Avian Influenza Vaccines Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Avian Influenza Vaccines Sales by Region (2024-2034) & (M Doses)
Table 88. Asia-Pacific Avian Influenza Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Avian Influenza Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Avian Influenza Vaccines Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Avian Influenza Vaccines Sales by Country (2018-2024) & (M Doses)
Table 92. Latin America Avian Influenza Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Avian Influenza Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Avian Influenza Vaccines Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Avian Influenza Vaccines Sales by Country (2024-2034) & (M Doses)
Table 96. Latin America Avian Influenza Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Avian Influenza Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Avian Influenza Vaccines Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Avian Influenza Vaccines Sales by Country (2018-2024) & (M Doses)
Table 100. Middle East and Africa Avian Influenza Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Avian Influenza Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Avian Influenza Vaccines Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Avian Influenza Vaccines Sales by Country (2024-2034) & (M Doses)
Table 104. Middle East and Africa Avian Influenza Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Avian Influenza Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Avian Influenza Vaccines Sales Market Share in Value by Country (2024-2034)
Table 107. Merial Company Information
Table 108. Merial Introduction and Business Overview
Table 109. Merial Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 110. Merial Avian Influenza Vaccines Product
Table 111. Merial Recent Development
Table 112. QYH Biotech Company Information
Table 113. QYH Biotech Introduction and Business Overview
Table 114. QYH Biotech Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 115. QYH Biotech Avian Influenza Vaccines Product
Table 116. QYH Biotech Recent Development
Table 117. DHN Company Information
Table 118. DHN Introduction and Business Overview
Table 119. DHN Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 120. DHN Avian Influenza Vaccines Product
Table 121. DHN Recent Development
Table 122. HVRI Company Information
Table 123. HVRI Introduction and Business Overview
Table 124. HVRI Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 125. HVRI Avian Influenza Vaccines Product
Table 126. HVRI Recent Development
Table 127. CEVA Company Information
Table 128. CEVA Introduction and Business Overview
Table 129. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 130. CEVA Avian Influenza Vaccines Product
Table 131. CEVA Recent Development
Table 132. Elanco (Lohmann ) Company Information
Table 133. Elanco (Lohmann ) Introduction and Business Overview
Table 134. Elanco (Lohmann ) Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 135. Elanco (Lohmann ) Avian Influenza Vaccines Product
Table 136. Elanco (Lohmann ) Recent Development
Table 137. Yebio Company Information
Table 138. Yebio Introduction and Business Overview
Table 139. Yebio Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 140. Yebio Avian Influenza Vaccines Product
Table 141. Yebio Recent Development
Table 142. Zoetis Company Information
Table 143. Zoetis Introduction and Business Overview
Table 144. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 145. Zoetis Avian Influenza Vaccines Product
Table 146. Zoetis Recent Development
Table 147. FATRO Company Information
Table 148. FATRO Introduction and Business Overview
Table 149. FATRO Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 150. FATRO Avian Influenza Vaccines Product
Table 151. FATRO Recent Development
Table 152. Kyoto Biken Company Information
Table 153. Kyoto Biken Introduction and Business Overview
Table 154. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 155. Kyoto Biken Avian Influenza Vaccines Product
Table 156. Kyoto Biken Recent Development
Table 157. CAVAC Company Information
Table 158. CAVAC Introduction and Business Overview
Table 159. CAVAC Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 160. CAVAC Avian Influenza Vaccines Product
Table 161. CAVAC Recent Development
Table 162. Ringpu Biology Company Information
Table 163. Ringpu Biology Introduction and Business Overview
Table 164. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 165. Ringpu Biology Avian Influenza Vaccines Product
Table 166. Ringpu Biology Recent Development
Table 167. Vaksindo Company Information
Table 168. Vaksindo Introduction and Business Overview
Table 169. Vaksindo Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 170. Vaksindo Avian Influenza Vaccines Product
Table 171. Vaksindo Recent Development
Table 172. ChengDu Tecbond Company Information
Table 173. ChengDu Tecbond Introduction and Business Overview
Table 174. ChengDu Tecbond Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 175. ChengDu Tecbond Avian Influenza Vaccines Product
Table 176. ChengDu Tecbond Recent Development
Table 177. Sindh Poultry Vaccine Centre Company Information
Table 178. Sindh Poultry Vaccine Centre Introduction and Business Overview
Table 179. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 180. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product
Table 181. Sindh Poultry Vaccine Centre Recent Development
Table 182. Merck Animal Health Company Information
Table 183. Merck Animal Health Introduction and Business Overview
Table 184. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 185. Merck Animal Health Avian Influenza Vaccines Product
Table 186. Merck Animal Health Recent Development
Table 187. Medion Company Information
Table 188. Medion Introduction and Business Overview
Table 189. Medion Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 190. Medion Avian Influenza Vaccines Product
Table 191. Medion Recent Development
Table 192. Avimex Animal Health Company Information
Table 193. Avimex Animal Health Introduction and Business Overview
Table 194. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 195. Avimex Animal Health Avian Influenza Vaccines Product
Table 196. Avimex Animal Health Recent Development
Table 197. JOVAC Company Information
Table 198. JOVAC Introduction and Business Overview
Table 199. JOVAC Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 200. JOVAC Avian Influenza Vaccines Product
Table 201. JOVAC Recent Development
Table 202. Bio-Labs Company Information
Table 203. Bio-Labs Introduction and Business Overview
Table 204. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2018-2024)
Table 205. Bio-Labs Avian Influenza Vaccines Product
Table 206. Bio-Labs Recent Development
Table 207. Key Raw Materials Lists
Table 208. Raw Materials Key Suppliers Lists
Table 209. Avian Influenza Vaccines Market Trends
Table 210. Avian Influenza Vaccines Market Drivers
Table 211. Avian Influenza Vaccines Market Challenges
Table 212. Avian Influenza Vaccines Market Restraints
Table 213. Avian Influenza Vaccines Distributors List
Table 214. Avian Influenza Vaccines Downstream Customers
Table 215. Research Programs/Design for This Report
Table 216. Key Data Information from Secondary Sources
Table 217. Key Data Information from Primary Sources
List of Figures
Figure 1. Avian Influenza Vaccines Product Picture
Figure 2. Global Avian Influenza Vaccines Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Avian Influenza Vaccines Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Avian Influenza Vaccines Sales Status and Outlook (2018-2034) & (M Doses)
Figure 5. Product Picture of H5+H7 Avian Influenza Vaccines
Figure 6. Global H5+H7 Avian Influenza Vaccines Sales YoY Growth (2018-2034) & (M Doses)
Figure 7. Product Picture of H9 Avian Influenza Vaccines
Figure 8. Global H9 Avian Influenza Vaccines Sales YoY Growth (2018-2034) & (M Doses)
Figure 9. Global Avian Influenza Vaccines Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Avian Influenza Vaccines Sales Market Share by Type in 2022 & 2034
Figure 11. North America Avian Influenza Vaccines Sales Market Share in Volume by Type in 2022
Figure 12. North America Avian Influenza Vaccines Sales Market Share in Value by Type in 2022
Figure 13. Europe Avian Influenza Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. Europe Avian Influenza Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Avian Influenza Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Avian Influenza Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Latin America Avian Influenza Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Avian Influenza Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Avian Influenza Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Avian Influenza Vaccines Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Avian Influenza Vaccines Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Avian Influenza Vaccines Revenue in 2022
Figure 23. Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Chicken Avian Influenza Vaccines
Figure 25. Global Chicken Avian Influenza Vaccines Sales YoY Growth (2018-2034) & (M Doses)
Figure 26. Product Picture of Duck & Goose Avian Influenza Vaccines
Figure 27. Global Duck & Goose Avian Influenza Vaccines Sales YoY Growth (2018-2034) & (M Doses)
Figure 28. Product Picture of Other
Figure 29. Global Other Sales YoY Growth (2018-2034) & (M Doses)
Figure 30. Global Avian Influenza Vaccines Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Avian Influenza Vaccines Sales Market Share by Application in 2022 & 2034
Figure 32. North America Avian Influenza Vaccines Sales Market Share in Volume by Application in 2022
Figure 33. North America Avian Influenza Vaccines Sales Market Share in Value by Application in 2022
Figure 34. Europe Avian Influenza Vaccines Sales Market Share in Volume by Application in 2022
Figure 35. Europe Avian Influenza Vaccines Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Avian Influenza Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Avian Influenza Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Latin America Avian Influenza Vaccines Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Avian Influenza Vaccines Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Avian Influenza Vaccines Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Avian Influenza Vaccines Manufacturing Cost Structure
Figure 43. Avian Influenza Vaccines Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries